RNA Outsourcing Resources

31. The Fast Track To Global Expansion: Consistency Across Every Site 8/27/2026

    Operational consistency across global facilities protects product integrity and supports growth. Standardized processes reduce risk, minimize variability, and strengthen quality across markets.

32. Bio/Pharmaceutical Facility Validation And Environmental Monitoring 6/11/2026

    Gain insight into how experienced validation and monitoring partners help organizations establish compliant operations, maintain facility performance, manage risk, and support long-term operational excellence.

33. How Global Supply Chain Centers Amplify CGT Program Growth 10/20/2025

    Consolidating logistics, cryopreservation, and storage eliminates handoffs and risk. This single-platform approach creates the consistency needed for global compliance and growth.

34. Mapping The Future: Q&A With Mark Sawicki, Ph.D., On 2025 Trends In CGT 2/25/2025

    Learn how you can stay ahead of the evolving cell and gene therapy landscape by leveraging innovative solutions to support the continued growth and success of therapies in 2025 and beyond.

35. Consolidating The Supply Chain For mRNA 2/12/2024

    Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.

36. Outsourcing RNA-LNP Production: A Key To Competitive Success 3/6/2025

    Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.

37. Redefining Biomanufacturing For Personalized Cancer Vaccines 4/24/2026

    Personalized cancer vaccines need fast, flexible manufacturing. Cell‑free synthetic DNA enables rapid, small‑batch mRNA production, supporting individualized therapies beyond plasmid‑based limits.

38. Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO 9/2/2025

    In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

39. Phase IIb Trial: Evaluating A Novel Treatment For Locally Advanced Or Metastatic Breast Cancer 12/5/2024

    This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.

40. Automated Cryo‑Processed Leukapheresis For CAR‑T Manufacturing 3/30/2026

    Automated, closed cryo‑processing of leukapheresis preserves cell quality and functionality, enabling flexible, reproducible starting material for both autologous and allogeneic CAR‑T manufacturing.